Schizophrenia: Overview and Treatment Options - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Despite growing awareness in the psychiatric community of the multifaceted medical needs
of the severely mentally ill, statistics show that as much as 60% of all schizophrenia patients …

This guideline has been developed to advise on the treatment and management of
psychosis and schizophrenia in adults. The guideline recommendations have been …

Over the last decade, a consensus has emerged regarding a set of evidence-based
practices for schizophrenia that address symptom management and psychosocial …

OBJECTIVE: The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study
examined the comparative effectiveness of antipsychotic treatments for individuals with …

OBJECTIVES: This study provided generalizable national data on the treatment of adult
patients with schizophrenia in the United States and assessed conformance with the …

Objectives Clinical practice guidelines (CPGs) support the translation of research evidence
into clinical practice. Key health questions in CPGs ensure that recommendations will be …

The guideline makes recommendations for the treatment and management of
schizophrenia. It aims to improve access and engagement with treatment and services for …

Guidelines for schizophrenia treatment have been created in various countries and have
been translated and used in Japan as well. However, the available drugs and their …